Description
Created On: 2020-07-15
Record Count: 4
Primary Industries
- Drugs
- Disease
- Osteoarthritis
- Proteins
- Therapeutic
- Delivery
- Hormones
- Assay
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 256298
Licensor grants an exclusive license, even as to Licensor, under the Licensed Technology, to make, have made, use, sell, offer for sale and import Licensed Product in the Territory in the Field and an exclusive license, even as to Licensor, under the Licensed Technology, to make, have made, use, and import Active Pharmaceutical Ingredient (API) and PTH in the Territory.
PTH means all forms of parathyroid hormone. Parathyroid hormone (PTH), also called parathormone or parathyrin, is a hormone secreted by the parathyroid glands that is important in bone remodeling, which is an ongoing process in which bone tissue is alternately resorbed and rebuilt over time.
Licensed Product means a drug product in finished pharmaceutical form, in any formulation containing or incorporating PTH, alone or in combination with any pharmacologically active ingredient which is a non-peptide or non-peptidomimetic or proprietary Licensee peptide, which product incorporates Licensor Know-How and/or is covered by Licensor Patent Rights and/or Joint Patent Rights.
The licensing agreement is to develop an oral formulation of an analog of PTH currently in clinical development for the treatment of osteoporosis.
IPSCIO Record ID: 256310
With this amendment, Licensor consents and agrees that Licensee may enter into one or more agreements with a designated Third Party providing for the development, manufacturing, marketing or sale of 1-34 PTH into a drug product in the Field in finished pharmaceutical form in an oral formulation containing or incorporating 1-34 PTH, alone or in combination with a peptide or a small molecule that is not proprietary to Licensor, and which such oral formulation of 1-34 PTH product incorporates Licensee Know-How or is covered by Licensee Patent Rights, a 1-34 PTH Product.
With this amendment, Licensor grants back to Licensee, but only to the extent necessary to effectuate the specific Third Party Agreement, an exclusive license, even as to Licensor, under the Licensed Technology that relates solely to the manufacturing of 1-34 PTH API for use solely in a 1-34 PTH Product for Licensee to make and sell to Third Party, and for Third Party as Licensee’s licensee to subsequently sell, have sold, make, have made and import 1-34 PTH API for use solely in a 1-34 PTH Product in the Territory in the Field. For the avoidance of doubt, the foregoing license back to Licensee shall only apply to Licensed Technology that is solely related to the manufacturing of 1-34 PTH API for use solely in a 1-34 PTH Product and not any other aspects of Licensed Technology such as, but not limited to, Licensed Technology as to the oral delivery method or amidation technology relating to 1-34 PTH API or a 1-34 PTH Product, and Licensor retains all other rights to the Licensed Technology granted to Licensor under the Agreement.
IPSCIO Record ID: 202864
The strategic alliance is to develop oral formulations of ForTeo (recombinant parathyroid hormone) and Humatrope (human growth hormone (HGH)) utilizing the Licensor's proprietary drug delivery technology.
IPSCIO Record ID: 266707
Licensor grants a perpetual, irrevocable, exclusive license, with the full right to sublicense, to use the Licensor Technology in the Field and in the Territory.
Product means an Oligonucleotide Formulation Product or a Special Product.
Oligonucleotide Formulation Product means an Oligonucleotide Delivery Composition the manufacture, use, or sale of which would constitute, but for the licenses granted Licensee pursuant to this Agreement, infringement of any issued, unexpired claim within the Licensor Patent Rights.
Special Product means any article, composition of matter, combination, device or kit other than an Oligonucleotide Formulation Product the manufacture, use, or sale of which would constitute, but for the licenses granted Licensee pursuant to this Agreement, infringement of any issued, unexpired claim within the Licensor Patent Rights.
Oligonucleotide Delivery Composition means any composition of matter that is complexed with an oligonucleotide composition (or analog of an oligonucleotide composition) for the delivery of such oligonucleotide composition (or analog of an oligonucleotide composition) to a targeted medium, including, but not limited to a biological organism, tissue or cell.